Skip to content
GLP-1 Desk
Menu
Dispatch #20

Direct Meds

A rare compounded desk offering both sublingual drops and injectable on either molecule, at all-inclusive no-membership pricing.

Visit Direct MedsAssume any provider we list may compensate us — it never changes the Desk Score.
Semaglutide
$179/mo
Tirzepatide
$224/mo
Coverage
Not publicly listed
Brand-name
Compounded only

Weigh Direct Meds against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Because Direct Meds dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access55/100
Molecule range88/100
Onboarding speed80/100
Support responsiveness76/100
Licensing & trust68/100

What the Desk likes

  • Rare oral/sublingual route offered alongside standard injection
  • All-inclusive pricing with no membership fee and no insurance needed
  • Both semaglutide and tirzepatide available

Where points come off

  • Compounded only — not FDA-approved
  • Pricing is company-stated in a press release, not independently verified on the live page
  • Newer entity operating across several similar domains
  • States-served list not disclosed

The Desk's briefing — B−

Best for: Patients who want a needle-free sublingual option, or the choice between drops and injection, without a membership fee.

Direct Meds ranks #20 of 30 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect Direct Meds's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Direct Meds's site. Not medical advice; see our disclosure.

← Back to The Desk